The Reverse Phase Protein Microarray Platform: A High-throughput Screening Method For Today’s Precision Medicine Needs
date21 April 2020
time & location11:00AM, Virtual
Join us April 21st, 2020 | 11:00am EDT
Join us as Dr. Denes Agoston discusses Reverse Phase Protein Arrays (RPPA), which have been successfully used in various aspects of neurology research.
RPPA is a robust, sensitive, and high throughput analytical platform that can be adapted to many other fields of biomedical research.
This presentation will discuss the advantages and challenges using the RPPA technology.
Speaker: Denes Agoston, MD, PhD
Founder and Chief Medical Officer of Neurometix LLC
Consulting and advising biopharmaceuticals in drug discovery and validation for CNS disorders.
Interested in learning more about RPPA technology in action? Watch our informative video on the Quanterix 2470 Arrayer.
Share this page